KROS icon

Keros Therapeutics
KROS

Overview Fund Activity

107 hedge funds and large institutions have $731M invested in Keros Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 20 closing their positions.

Holders
107
Holders Change
-16
Holders Change %
-13.01%
% of All Funds
1.71%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
4
Increased
48
Reduced
29
Closed
20
Calls
$1.67M
Puts
$3K
Net Calls
+$1.67M
Net Calls Change
+$1.17M

Top Buyers

1
WP
1
Woodline Partners
California
$22.9M
2
Morgan Stanley
2
Morgan Stanley
New York
$14.3M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$44.8M
4
B
4
Braidwell
Connecticut
$43.3M
5
Millennium Management
5
Millennium Management
New York
$6.51M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$115M
2
CI
2
Clal Insurance
Israel
$0
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$4.77M
4
NCM
4
Nantahala Capital Management
Connecticut
$10.5M
5
State Street
5
State Street
Massachusetts
$28.8M
Name Market Value Shares Shares
Change 		Shares
Change %
QCG
126
Quadrant Capital Group
Ohio
– – -6 Closed
CFGS
127
Concourse Financial Group Securities
Alabama
– – – –
C
128
Covestor
United Kingdom
$0 3 – –
2 3 4 5
6